참고문헌 (29)

1. https://www.who.int/westernpacific/emergencies/covid-19. 

2. Nacoti M, Ciocca A, Giupponi A, Brambillasca P, Lussana F, Pisano M, et al. At the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Catal Innov Care Deliv. Forthcoming;2020. 

3. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline. 

4. Sun, P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis. Journal of Medical Virology 2020;92:612-617. 

   상세보기

5. Kang EK, Lee SY, Jung HM, Kim MS, Cho BL, Kim YS. Operating protocols of a community treatment center for isolation of patients with coronavirus disease, South Korea. Emerging Infectious Diseases 2020;26:2329-2337. 

   상세보기

6. Hyun JH, You SE, Sohn SJ, Kim SJ, Bae JY, Baik MJ, et al. Psychosocial support during the COVID-19 outbreak in Korea: activities of multidisciplinary mental health professionals. J Korean Med Sci 2020;35:e211. 

   상세보기

7. Park HY. Mental health in patients with coronavirus disease-19 and the quarantined people. J Korean Neuropsychiatr Assoc 2021;60:11-18. 

8. Park HY, Jung JT, Park HY, Lee SH, Kim ES, Kim HB, et al. Psychological consequences of survivors of COVID-19 pneumonia 1 month after discharge. J Korean Med Sci 2020;35:e409. 

   상세보기

9. Maxime T, John RG, Masud H, Sierra L, Paul JH. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry 2021:8:416-427. 

   상세보기

10. Wang CY, Pan RY, Wan XY, Tan YL, Xu LK, McIntyre RS, et al. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain, Behavior, and Immunity 2020;87:40-48. 

    상세보기

11. Lee YH, Hong CM, Kim DH, Lee TH, Lee J. Clinical course of asymptomatic and mildly symptomatic patients with coronavirus disease admitted to community treatment centers, South Korea. Emerg Infect Dis 2020;26:2346-2352. 

    상세보기

12. Chen D, Song F, Tang L, Zhang H, Shao J, Qiu R, et al. Quarantine experience of close contacts of COVID-19 patients in China: a qualitative descriptive study. Gen Hosp Psychiatry 2020;66:81-88. 

13. Korenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care 2003;41:1284-1292. 

    상세보기

14. Choi HS, Choi JH, Park KH, Joo KJ, Ga H, Ko HJ, et al. Standardization of the Korean version of Patient Health Questionnaire-9 as a screening instrument for major depressive disorder. Korean J Fam Med 2007;28:114-119. 

15. Swinson RP. The GAD-7 scale was accurate for diagnosing generalised anxiety disorder. Evid Based Med 2006;11:184. 

    상세보기

16. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007;146:317-325. 

    상세보기

17. Seo JG, Park SP. Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. J Headache Pain 2015;16:97. 

18. Prins A, Bovin MJ, Smolenski DJ, Marx BP, Kimerling R, Jenkins- Guarnieri MA, et al. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): development and evaluation within a Veteran primary care sample. J GEN INTERN MED 2016;31:1206-1211. 

    상세보기

19. Jung YE, Kim D, Kim WH, Roh D, Chae JH, Park JE. A brief screening tool for PTSD: Validation of the Korean Version of the Primary Care PTSD Screen for DSM-5 (K-PC-PTSD-5). J Korean Med Sci 2018;33:52. 

20. Dube P, Kurt K, Bair MJ, Theobald D, Williams LS. The p4 screener: evaluation of a brief measure for assessing potential suicide risk in 2 randomized effectiveness trials of primary care and oncology patients. Primary Care Companion J Clin Psychiatry 2010;12:6. 

21. Beard C, Bjorgvinsson T. Beyond generalized anxiety disorder: psychometric properties of the GAD-7 in a heterogeneous psychiatric sample. J Anxiety Disord 2014;28:547-552. 

22. Lee YM. National Mental Health Statistics 2020. National Center for Mental Health;2021. 

23. Hahm BJ. National Mental Health Survey 2021. National Center for Mental Health;2021. 

24. Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). J Traum Stress 2005;18:39-42. 

25. Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, et. al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann NY Acad Sci 2021;1486:90-111. 

    상세보기

26. Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, et al. Depressive and anxiety symptoms in patients with SARSCoV2 infection. J Affect Disord 2021;278:339-340. 

27. Zhao YJ, Jin W, Rao WW, Li W, Zhao N, Cheung T, et al. The prevalence of psychiatric comorbidities during the SARS and COVID-19 epidemics: a systematic review and meta-analysis of observational studies. Journal of Affective Disorders 2021;287:145-157. 

    상세보기

28. Response Guidance for Businesses to prevent and control the spread of COVID-19 Eighth edition. Ministry of Employment and labor;2020. 

29. Rutter LA, Brown TA. Psychometric properties of the Generalized Anxiety Disorder Scale-7 (GAD-7) in outpatients with anxiety and mood disorders. J Psychopathol Behav Assess 2017;39:140-146. 

    상세보기